Skip to main content
Premium Trial:

Request an Annual Quote

BioRegion Newsmakers: Apr 6, 2009


Food & Drug Policy Expert James Czaban Joins Law Firm Wiley Rein

James Czaban has joined the food & drug and product safety practice of the law firm Wiley Rein.

Czaban previously worked at the Washington, DC, office of the law firm WilmerHale, where he co-chaired the law firm's FDA group. He has specialized in legal, regulatory, and policy matters for pharmaceutical, biotechnology, food, medical device, and life sciences clients. Czaban is a member of the editorial advisory boards of the Bureau of National Affairs' Pharmaceutical Law and Industry Report and the journal Drug Delivery Technology.

Czaban received his JD degree from the University of Virginia School of Law, and his undergraduate degree from the University of California, Berkeley.

Successful Biotech Recruitment Effort Nets Man of the Year Honor for Arvada Economic Development Leader

Frank Barone, the vice president of the Arvada (Colo.) Economic Development Association, has been named Man of the Year for 2009 by the city of Arvada.

Barone was cited in part for his role with a group of AEDA members in persuading Sartorius to expand a regional office in Arvada rather than other sites. Hazel Hartbarger, director of the Arvada Economic Development Association, told Mile High Newspapers the deal was successful because Barone spoke with Sartorius executives from the position of a fellow business owner, not a government official.

Barone is the owner of a namesake manufacturer of industrial vacuum excavation equipment. In addition to his duties there and at AEDA, Barone is a member and former president of the Arvada Chamber of Commerce, a member of the Arvada Kiwanis Club, and a member of the Jefferson County Open Space Advisory Committee, which makes decisions about the county's 51,000 acres of open space.

He also volunteers at the Arvada Community Food Bank, where he co-chairs the capital campaign committee now trying to raise $300,000 to repair the food bank, and then move it into a larger facility. "You do the work in front of you. That's what I've always done," he told Mile High.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.